20
Zydus Lifesciences Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is BUSPIRONE HYDROCHLORIDE USP, with a corresponding US DMF Number 33431.
Remarkably, this DMF maintains an Active status since its submission on December 28, 2018, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of February 25, 2019, and payment made on December 20, 2018, indicating their dedication to facilitating drug approvals, Categorized as Type II